0,940  0,002  NOS2 expression inhibitor
0,919  0,002  UGT1A9 substrate
0,918  0,004  Chemoprotective
0,886  0,004  CYP2C19 substrate
0,879  0,002  Monophenol monooxygenase inhibitor
0,860  0,002  Melanin inhibitor
0,860  0,003  Skin whitener
0,859  0,010  Apoptosis agonist
0,850  0,002  UGT1A3 substrate
0,846  0,002  UGT1A1 substrate
0,845  0,005  Antihypercholesterolemic
0,836  0,004  Antioxidant
0,829  0,007  TNF expression inhibitor
0,833  0,011  Antiinflammatory
0,818  0,004  Lipoxygenase inhibitor
0,809  0,005  Chemopreventive
0,804  0,004  UGT1A6 substrate
0,801  0,013  Transcription factor NF kappa B inhibitor
0,784  0,005  CYP1A2 substrate
0,783  0,005  Sensitization
0,772  0,004  Free radical scavenger
0,779  0,021  Alpha-glucosidase inhibitor
0,756  0,005  Caspase 3 stimulant
0,760  0,009  15-Lipoxygenase inhibitor
0,751  0,004  UDP-glucuronosyltransferase substrate
0,738  0,005  Proliferative diseases treatment
0,737  0,019  Caspase 9 stimulant
0,716  0,003  Amylase inhibitor
0,716  0,004  Genotoxic
0,716  0,005  CYP1A2 inhibitor
0,713  0,004  Histamine release inhibitor
0,713  0,005  AR expression inhibitor
0,723  0,017  Antineoplastic (breast cancer)
0,677  0,005  Antineoplastic (brain cancer)
0,675  0,005  CYP2C19 inhibitor
0,684  0,020  Antineoplastic (lung cancer)
0,674  0,013  Carcinogenic
0,668  0,007  Nitric oxide antagonist
0,665  0,008  Antiosteoporotic
0,660  0,003  Beta glucuronidase inhibitor
0,656  0,003  Estrogen receptor alpha antagonist
0,670  0,017  Cyclophilin D inhibitor
0,670  0,017  Antidiabetic
0,657  0,005  Hypoxia-inducible factor 1 alpha inhibitor
0,642  0,005  MAO inhibitor
0,643  0,010  Bone diseases treatment
0,635  0,010  Cytostatic
0,639  0,024  CYP3A4 substrate
0,614  0,010  Antiparasitic
0,606  0,005  Myocardial infarction treatment
0,601  0,005  Antihypertriglyceridemic
0,613  0,017  Antibacterial
0,607  0,012  Spasmolytic
0,597  0,002  Antihemorrhagic
0,597  0,008  Amyloid beta aggregation inhibitor
0,591  0,005  Antihypoxic
0,603  0,017  Respiratory analeptic
0,591  0,007  Antihelmintic
0,589  0,009  Hypoglycemic
0,589  0,012  Cardiovascular analeptic
0,584  0,011  Apoptosis antagonist
0,594  0,024  Alzheimer's disease treatment
0,576  0,007  Vascular (periferal) disease treatment
0,593  0,025  Antileukemic
0,569  0,003  Neurotrophic factor enhancer
0,574  0,016  Mutagenic
0,566  0,008  Antimutagenic
0,566  0,011  Antineoplastic (glioma)
0,570  0,015  12-Lipoxygenase inhibitor
0,552  0,004  Protein-tyrosine phosphatase 1B inhibitor
0,550  0,004  Protein-tyrosine phosphatase inhibitor
0,547  0,003  Aromatase inhibitor
0,548  0,004  Breast cancer-resistant protein inhibitor
0,553  0,015  Hepatic disorders treatment
0,539  0,004  UGT2B15 substrate
0,550  0,018  Radioprotector
0,533  0,004  Estrogen receptor beta antagonist
0,552  0,024  Prostate cancer treatment
0,545  0,018  Analeptic
0,538  0,013  Antiamyloidogenic
0,529  0,019  CYP2C9 inhibitor
0,528  0,019  Antineoplastic (cervical cancer)
0,523  0,014  Antiprotozoal (Leishmania)
0,512  0,005  Lipid peroxidase inhibitor
0,516  0,010  Antineoplastic enhancer
0,510  0,007  Hepatoprotectant
0,514  0,011  Vasodilator
0,506  0,007  Antineoplastic (squamous cell carcinoma)
0,504  0,005  VCAM1 expression inhibitor
0,504  0,005  Antihypotensive
0,501  0,005  MAO B inhibitor
0,501  0,008  Antiulcerative
0,519  0,033  Antineoplastic (colorectal cancer)
0,509  0,023  Cytotoxic
0,515  0,029  Antipruritic, allergic
0,508  0,024  CYP2D6 substrate
0,512  0,030  Immunosuppressant
0,512  0,031  Teratogen
0,497  0,022  Antifungal
0,504  0,033  Antineoplastic (colon cancer)
0,490  0,022  Antineoplastic (pancreatic cancer)
0,470  0,004  Estrogen antagonist
0,460  0,006  5 Hydroxytryptamine uptake stimulant
0,468  0,019  ICAM1 expression inhibitor
0,451  0,002  Papain-like protease (SARS coronavirus) inhibitor
0,450  0,006  NOS3 expression enhancer
0,448  0,005  5-Lipoxygenase inhibitor
0,463  0,028  Cardioprotectant
0,445  0,011  UGT1A4 substrate
0,437  0,003  Histidine decarboxylase inhibitor
0,450  0,019  Superoxide dismutase inhibitor
0,461  0,034  Streptokinase A inhibitor
0,461  0,035  Embryotoxic
0,432  0,008  GST M1-1 substrate
0,424  0,004  Xanthine oxidase inhibitor
0,423  0,004  Dementia treatment
0,420  0,004  Vascular dementia treatment
0,420  0,004  SULT1A3 substrate
0,437  0,022  Antineoplastic (glioblastoma multiforme)
0,444  0,029  NOS3 expression inhibitor
0,446  0,039  Antithrombotic
0,434  0,030  CTGF expression inhibitor
0,402  0,003  Antiviral (SARS coronavirus)
0,402  0,003  Antiviral (Coronavirus)
0,430  0,032  Lipoprotein disorders treatment
0,401  0,004  Cholesterol synthesis inhibitor
0,419  0,040  Antineoplastic (ovarian cancer)
0,416  0,037  Antineoplastic (melanoma)
0,430  0,053  CYP2C9 substrate
0,393  0,017  P-glycoprotein inhibitor
0,377  0,003  Ca(v)3.2 blocker
0,387  0,014  Antineoplastic (carcinoma)
0,430  0,057  Antiprotozoal
0,375  0,002  Ornithine decarboxylase inhibitor
0,371  0,008  Acetylcholinesterase inhibitor
0,386  0,027  Antidiabetic symptomatic
0,392  0,042  Antimycobacterial
0,357  0,009  Cyclooxygenase 1 inhibitor
0,375  0,033  Antiprotozoal (Trypanosoma)
0,372  0,034  Antipyretic
0,343  0,006  Expectorant
0,351  0,019  Platelet adhesion inhibitor
0,338  0,008  Alkaline phosphatase inhibitor
0,338  0,010  Antidiarrheal
0,358  0,032  Antineoplastic (liver cancer)
0,361  0,039  Antineoplastic (multiple myeloma)
0,326  0,004  Gastritis treatment
0,336  0,014  Gastrin inhibitor
0,330  0,008  Antitussive
0,323  0,004  Mucolytic
0,320  0,003  Ca(v)3.1 blocker
0,359  0,042  Antidiabetic (type 2)
0,315  0,005  Estrogen agonist
0,350  0,043  Antineoplastic (non-small cell lung cancer)
0,312  0,007  Topoisomerase II alpha inhibitor
0,342  0,038  Antineoplastic (renal cancer)
0,328  0,024  Dual specificity phosphatase inhibitor
0,314  0,012  Phospholipase A2 inhibitor
0,327  0,027  RNA-directed DNA polymerase inhibitor
0,303  0,007  Androgen antagonist
0,339  0,044  Antineoplastic (osteosarcoma)
0,304  0,009  Cystathionine beta-synthase inhibitor
0,298  0,004  Lipase inhibitor
0,305  0,014  MAO A inhibitor
0,302  0,016  Diabetic nephropathy treatment
0,297  0,011  UGT2B9 substrate
0,326  0,041  Antiglaucomic
0,363  0,081  GST A substrate
0,278  0,004  Estrogen receptor beta agonist
0,293  0,019  Topoisomerase II inhibitor
0,291  0,020  Cholinergic
0,328  0,059  Aldehyde oxidase inhibitor
0,273  0,005  AMP-activated protein kinase stimulant
0,292  0,025  Pneumotoxic
0,321  0,056  Antituberculosic
0,310  0,046  Hypolipemic
0,291  0,029  UGT2B7 substrate
0,268  0,009  Antibacterial (Helicobacter pylori)
0,263  0,005  Creatine kinase inhibitor
0,277  0,020  Bone formation stimulant
0,312  0,057  UGT2B4 substrate
0,342  0,090  GABA C receptor rho-3 antagonist
0,257  0,005  Electron transport complex I inhibitor
0,278  0,027  Antiviral (Herpes)
0,301  0,053  Tumour necrosis factor alpha release inhibitor
0,267  0,026  Insulin sensitizer
0,255  0,016  Chelator
0,323  0,086  Antiprotozoal (Plasmodium)
0,282  0,049  Antineoplastic (sarcoma)
0,309  0,076  Immunostimulant
0,254  0,025  Protein kinase stimulant
0,235  0,007  NAD(P)H dehydrogenase (quinone) inhibitor
0,227  0,004  Fatty acid synthase inhibitor
0,226  0,004  Neuraminidase inhibitor
0,237  0,016  Antineoplastic antibiotic
0,221  0,007  Postmenopausal disorders treatment
0,287  0,074  5 Hydroxytryptamine release stimulant
0,231  0,021  Glutathione S-transferase substrate
0,223  0,022  DNA polymerase I inhibitor
0,217  0,019  Arachidonic acid antagonist
0,273  0,075  Antineurogenic pain
0,212  0,016  Sulfotransferase substrate
0,224  0,033  Cyclooxygenase inhibitor
0,303  0,114  Antiobesity
0,236  0,049  Non-steroidal antiinflammatory agent
0,184  0,005  Neuraminidase (influenza) inhibitor
0,256  0,077  DNA damaging
0,180  0,005  Estrogen receptor alpha agonist
0,208  0,034  Heat shock protein 90 antagonist
0,240  0,073  Antineoplastic (lymphocytic leukemia)
0,208  0,043  Succinate dehydrogenase inhibitor
0,224  0,059  Antiviral (Influenza)
0,183  0,021  Coagulant
0,249  0,088  Huntington's disease treatment
0,279  0,120  Stroke treatment
0,171  0,015  Phosphodiesterase 4D inhibitor
0,181  0,025  Microtubule formation inhibitor
0,258  0,109  CYP3A4 inhibitor
0,210  0,064  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,182  0,037  Neurotrophic factor
0,200  0,055  LDLR expression enhancer
0,176  0,032  Antifungal (Cryptococcus)
0,290  0,149  Antiparkinsonian
0,169  0,028  Butyrylcholinesterase inhibitor
0,188  0,047  UGT2B10 substrate
0,200  0,060  Dual specificity phosphatase 3 inhibitor
0,218  0,081  Antiviral (West Nile virus)
0,161  0,025  UGT2B1 substrate
0,168  0,031  Carcinogenic, group 2B
0,138  0,003  Retinoid X alpha receptor agonist
0,202  0,070  Abortion inducer
0,154  0,023  Multidrug resistance-associated protein 1 inhibitor
0,139  0,009  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,179  0,051  Interferon gamma antagonist
0,159  0,031  SULT1A1 substrate
0,162  0,037  Topoisomerase I inhibitor
0,173  0,048  Tubulin antagonist
0,179  0,054  Antiviral (Influenza A)
0,187  0,063  Mcl-1 antagonist
0,161  0,040  Cyclooxygenase 3 inhibitor
0,191  0,071  VEGF expression inhibitor
0,210  0,090  Angiogenesis stimulant
0,123  0,004  Transcription factor RelA inhibitor
0,148  0,029  Mediator release inhibitor
0,155  0,037  Beta amyloid protein antagonist
0,176  0,058  Interleukin 6 antagonist
0,128  0,014  Leukotriene antagonist
0,161  0,047  Cyclooxygenase 2 inhibitor
0,152  0,038  Ca2+-transporting ATPase inhibitor
0,243  0,130  Cholesterol antagonist
0,253  0,140  Ulceration
0,146  0,034  TRPA1 agonist
0,159  0,049  NADPH oxidase inhibitor
0,147  0,037  Antineoplastic (uterine cancer)
0,132  0,023  SULT1E1 substrate
0,220  0,111  Transcription factor STAT3 inhibitor
0,113  0,005  Glucose-6-phosphate translocase inhibitor
0,182  0,074  Antipruritic, non-allergic
0,121  0,014  Antiviral (Hepatitis A)
0,121  0,014  Aldose reductase inhibitor
0,129  0,027  Carbonic anhydrase XIII inhibitor
0,113  0,012  Xanthine dehydrogenase inhibitor
0,216  0,116  Transcription factor STAT inhibitor
0,235  0,135  Angiogenesis inhibitor
0,117  0,018  Na+ K+ transporting ATPase inhibitor
0,195  0,097  Nitric-oxide synthase stimulant
0,237  0,142  Sodium/bile acid cotransporter inhibitor
0,119  0,025  Inducible nitric-oxide synthase inhibitor
0,177  0,082  Antieczematic atopic
0,134  0,040  HDL-cholesterol increasing
0,114  0,021  HIV-1 integrase (3'-Processing) inhibitor
0,100  0,008  Cathepsin L2 inhibitor
0,097  0,005  Retinoid X receptor agonist
0,157  0,066  Antidote
0,153  0,064  Antiprotozoal (Coccidial)
0,115  0,026  Dyspepsia treatment
0,114  0,026  Opioid kappa receptor antagonist
0,109  0,022  Leukotriene synthesis inhibitor
0,110  0,023  Peroxisome proliferator-activated receptor gamma agonist
0,250  0,165  Atherosclerosis treatment
0,144  0,060  Farnesoid X receptor antagonist
0,164  0,081  Phospholipase C inhibitor
0,146  0,063  Antiacne
0,146  0,065  Histone deacetylase SIRT1 inhibitor
0,164  0,083  Toxic, respiratory center
0,110  0,030  Antibiotic
0,139  0,061  Antiprotozoal (Trichomonas)
0,113  0,034  Antiviral (Rhinovirus)
0,121  0,043  Carbonic anhydrase III inhibitor
0,103  0,026  CDC25A inhibitor
0,126  0,050  Photosensitizer
0,120  0,045  DOPA decarboxylase inhibitor
0,171  0,097  CYP2B6 inhibitor
0,185  0,113  Platelet antagonist
0,203  0,130  Tyrosine 3 hydroxylase inhibitor
0,078  0,008  Pregnane X receptor antagonist
0,081  0,013  Postcoital contraceptive
0,082  0,015  Leukotriene B4 antagonist
0,159  0,095  DNA methyltransferase I inhibitor
0,124  0,060  Antiviral (Influenza B)
0,076  0,014  Carbonic anhydrase VII inhibitor
0,168  0,106  Antimitotic
0,108  0,047  UGT2B11 substrate
0,092  0,031  SULT1A2 substrate
0,110  0,050  Anabolic
0,112  0,053  Carbonic anhydrase XV inhibitor
0,072  0,014  Opioid kappa receptor agonist
0,106  0,047  Uric acid excretion stimulant
0,085  0,028  HIV-1 integrase (Strand Transfer) inhibitor
0,139  0,083  Adenylate cyclase stimulant
0,141  0,087  Eye irritation, high
0,071  0,017  Dihydroorotate oxidase inhibitor
0,119  0,066  Proteasome inhibitor
0,068  0,015  Leukocyte elastase inhibitor
0,070  0,017  Acetyl-CoA transferase 2 inhibitor
0,086  0,034  HIV-1 integrase inhibitor
0,120  0,068  Alkylator
0,173  0,120  Antineoplastic (lymphoma)
0,113  0,063  Skin irritative effect
0,170  0,122  Cyclic AMP phosphodiesterase inhibitor
0,107  0,059  Urease inhibitor
0,086  0,038  Narcotic antagonist
0,052  0,004  Inosine monophosphate dehydrogenase 1 inhibitor
0,145  0,098  Liver fibrosis treatment
0,125  0,078  Interleukin 4 antagonist
0,073  0,026  Calcium channel T-type blocker
0,106  0,060  Toll-Like receptor 4 antagonist
0,059  0,014  Neuraminidase (Influenza A) inhibitor
0,150  0,105  Death-associated protein kinase 2 inhibitor
0,096  0,051  Opioid antagonist
0,054  0,012  Retinoic acid alpha receptor agonist
0,116  0,073  Alcohol dehydrogenase substrate
0,135  0,096  GABA C receptor rho-2 antagonist
0,155  0,116  Antirickettsial
0,214  0,175  FMO1 substrate
0,153  0,115  Cardiodepressant
0,080  0,042  Antitreponemal
0,079  0,042  Phosphodiesterase VI inhibitor
0,129  0,092  Peroxidase inhibitor
0,166  0,131  Antiviral (HIV)
0,126  0,091  Cell wall synthesis inhibitor
0,057  0,022  Sodium/calcium exchanger inhibitor
0,067  0,034  Transcription factor AP-1 inhibitor
0,142  0,111  Amyloid beta precursor protein antagonist
0,090  0,059  Actinic keratosis treatment
0,070  0,041  Glucagon-like peptide 1 agonist
0,108  0,079  Carcinogenic, group 3
0,045  0,018  Inosine monophosphate dehydrogenase inhibitor
0,097  0,070  Antiviral (Poxvirus)
0,051  0,024  Estradiol 17 beta-dehydrogenase inhibitor
0,059  0,032  Leukotriene C antagonist
0,094  0,068  UDP-glucose 4-epimerase inhibitor
0,044  0,019  Retinoid X receptor antagonist
0,051  0,029  Cholesterol esterase inhibitor
0,079  0,058  Glycine receptor antagonist
0,094  0,073  Gastric antisecretory
0,099  0,079  GABA C receptor antagonist
0,035  0,015  Leukotriene B4 receptor 1 antagonist
0,099  0,079  GST T1-1 substrate
0,037  0,018  Tubulin agonist
0,037  0,019  Retinoid X alpha receptor antagonist
0,108  0,092  Contraceptive female
0,131  0,115  Prostate disorders treatment
0,029  0,014  Sodium/glucose cotransporter 2 inhibitor
0,113  0,098  Antifungal enhancer
0,039  0,025  5-Alpha-reductase inhibitor
0,122  0,109  Hemostatic
0,105  0,093  Constipation treatment
0,128  0,115  Antihelmintic (Nematodes)
0,066  0,054  Exportin-1 inhibitor
0,052  0,041  Protein kinase C eta inhibitor
0,050  0,040  Opioid agonist
0,024  0,014  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,068  0,058  Peroxisome proliferator-activated receptor gamma antagonist
0,026  0,017  Sodium/glucose cotransporter inhibitor
0,131  0,122  Movement disorders treatment
0,050  0,041  Alpha tubulin antagonist
0,066  0,058  Secretase beta inhibitor
0,038  0,030  Leukotriene C4 antagonist
0,024  0,017  Sodium/glucose cotransporter 1 inhibitor
0,030  0,023  Cholesterol ester transfer protein antagonist
0,030  0,024  Squalene synthetase inhibitor
0,069  0,063  Analgesic, opioid
0,049  0,043  Vanilloid 2 antagonist
0,043  0,037  Microtubule stabilization
0,025  0,019  Leukotriene D4 antagonist
0,022  0,017  Dopamine D1 agonist
0,055  0,050  Opioid delta receptor antagonist
0,126  0,122  Uterine stimulant
0,046  0,043  Squalene epoxidase inhibitor
0,018  0,016  Inosine monophosphate dehydrogenase 2 inhibitor
0,097  0,095  M18 aspartyl aminopeptidase inhibitor
0,030  0,029  Estrogen-related receptor beta antagonist
0,041  0,040  Opioid mu receptor agonist
0,062  0,061  Prostaglandin-E synthase inhibitor
0,019  0,019  Neuraminidase (Influenza B) inhibitor

